Follow Our Live Coverage of COVID-19 Developments

Genetic Disorder News

Date Posted
Article Title
7/16/2020
5/27/2020
4/14/2020
FDA Approves Koselugo for Pediatric Neurofibromatosis Type 1

Approval based on data showing 66 percent overall response rate

3/30/2020
2/20/2020
2/6/2020
2/6/2020
2/5/2020
1/10/2020
11/22/2019
Givlaari Approved for Acute Hepatic Porphyria

Subcutaneous injection once monthly aims to help reduce the number of porphyria attacks

11/21/2019
11/19/2019
11/1/2019
10/22/2019
9/13/2019
8/20/2019
8/13/2019
6/20/2019
6/4/2019
5/28/2019
5/23/2019
5/22/2019
4/18/2019
3/25/2019
3/14/2019
3/14/2019
2/19/2019
1/23/2019
1/17/2019
1/14/2019
12/14/2018
12/6/2018
11/7/2018
10/9/2018
10/2/2018
9/26/2018
8/17/2018
8/16/2018
8/14/2018
8/9/2018
8/9/2018
8/7/2018